MedPath

Adherence to Intravitreal anti VEGF Injections in Patients with Diabetic Macular Edema

Not Applicable
Conditions
Health Condition 1: H358- Other specified retinal disorders
Registration Number
CTRI/2022/07/044292
Lead Sponsor
Dr Lam Sudha Rani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diabetic Macular Edema Patients Who Were Diagnosed Clinically and Confirmed with Spectral Domain OCT and Who are Candidates for Repeated Intravitreal anti VEGF Injections

Exclusion Criteria

Patients receiving Intravitreal anti VEGF injections for

Neovascular AMD

Vein Occlusions

Post Operative Macular Edema

Cystoid Macular Edema

Uveitis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We Expect that Non Adherence to Repeated Intravitreal anti VEGF Injections in Diabetic Macular Edema Patients will be Positively Correlated to Low Socioeconomic Status Age Knowledge about the Disease Reachability of the Hospital Anxiousness Perceived Benefits Perceived Seriousness Perceived Susceptibility and Perceived BarriersTimepoint: Baseline
Secondary Outcome Measures
NameTimeMethod
To know about the correlation between the demographic characteristics of patients and adherence to intravitreal anti VEGFs <br/ ><br>To know how much the knowledge about the disease will affect their adherence <br/ ><br>To know about the perceived seriousness perceived susceptibility perceived benefits and about the perceived barriers <br/ ><br>Timepoint: Baseline
© Copyright 2025. All Rights Reserved by MedPath